Everstone Capital Deploys $270 Million Into Specialty Pharma Group Apothecon
Singapore-based private equity firm Everstone Capital has agreed to invest close to $270 million for a significant stake in Apothecon Group, a specialty pharmaceutical platform spanning India-based